Description

4-[(6-Methylimidazo[1,2-A]Pyridin-2-Yl)Methoxy]Benzoic Acid is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound matters for its critical role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring targeted molecular design. It is primarily needed by research institutions and pharmaceutical manufacturers engaged in the development of new chemical entities, especially for applications in oncology and central nervous system (CNS) disorders.

Application

• Pharmaceutical Intermediate: A crucial precursor in the multi-step synthesis of investigational new drugs and proprietary APIs.
• Medicinal Chemistry Research: Serves as a versatile scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Oncology Drug Development: Used in the research and production of targeted cancer therapies due to its specific imidazopyridine core.
• CNS-Active Compound Synthesis: Employed in creating potential treatments for neurological and psychiatric conditions.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations providing custom synthesis and scale-up services for the pharmaceutical industry.
• Academic Research: Utilized in university and institutional labs for biochemical and pharmacological studies.

Basic Information

Product Name	4-[(6-Methylimidazo[1,2-A]Pyridin-2-Yl)Methoxy]Benzoic Acid
CAS No.	929975-01-9
Molecular Formula	C16H14N2O3
Molecular Weight	282.30 g/mol
Synonyms	4-[(6-Methylimidazo[1,2-a]pyridin-2-yl)methoxy]benzoic acid; 4-((6-Methylimidazo[1,2-a]pyridin-2-yl)methoxy)benzoic Acid; Benzoic acid, 4-[(6-methylimidazo[1,2-a]pyridin-2-yl)methoxy]-; 929975-01-9; 4-(6-Methylimidazo[1,2-a]pyridin-2-ylmethoxy)benzoic acid
EINECS	Contact for details

Quality Control

Our 4-[(6-Methylimidazo[1,2-A]Pyridin-2-Yl)Methoxy]Benzoic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D and cGMP manufacturing. A comprehensive Certificate of Analysis (COA) detailing all test results is provided with every shipment and is available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider inert atmosphere conditions to ensure maximum stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.